Sunny - <OFF TOPIC>
In my view, the idea of entering the biotech sector as a counterweight to another lagging sector is a highly questionable premise. This is especially true when fleeing the volatile, though earnings driven, semiconductor world to the realm of dream cures and rapid burn rates (the rate at which a company consumes investment capital). The burn rate implies, of course, years and years of substantial loses with the payoff dependent upon mother nature supporting the research hypothesis.
Regardless of all that, and despite the fact that I do follow (read: own stock in) some BT companies, I won't 'reveal' any of them. There's a simple reason for this: my interest was and is generated by the 'intellectual' capital, the research muscle, and not by earnings. Very idealistic...but it's easy to misconstrue brains for business savvy.
So I'll say this: the wisest thing to do is to go for big pharma (Merck, Pfizer. Lilly, J & J, etc.). If that's too boring, search for biotechs with a history of earnings (more likely in the medical device than pharmaceutical arena), and be very, very patient. |
